BioBusiness

Articles

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

 Washington Editor, jillwechsler7@gmail.com.

A new initiative aims to speed the approval of and access to new drugs for young patients around the world, while limiting the number of children needed for testing in clinical trials.

New Guidelines Aim to Advance Pediatric Drug Development

Feliza Mirasol is the science editor for 

Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.

Shining a Spotlight on Nucleic Acid-Based Therapeutics

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

With high-concentration biologics, careful selection of excipients in formulation is crucial for reducing viscosity without destabilizing the protein.

Developing Excipients for High-Concentration Biologic Formulations

NIH has announced four new grant awards to fund new tuberculosis research advancement centers. 

NIH Funds New Tuberculosis Research Advancement Centers

The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.

Nucleic Acid-based Therapeutics Are Stepping into the Spotlight

Mark White, PhD, is the associate director of Biopharma Product Marketing at Bio-Rad.

Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.

CAR-T cell therapy development is a complex process that requires standardization.

Assessing the Quality of CAR-T Cells Using ddPCR

SCG Cell Therapy has signed a collaboration agreement with A*STAR’s BTI to advance the development of antibodies for infectious diseases and cancer treatments.

SCG Cell Therapy and A*STAR’s BTI Collaborate to Advance Multi-Specific Antibody Development 

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

A rise in investments and funding into regenerative medicines projects has helped to advance a rich clinical pipeline. 

Biologic Drugs in Development